Showing 81-90 of 1560 results for "".
The Need to Preserve Beta Cell Function Early
https://reachmd.com/programs/diabetes-discourse/the-need-to-preserve-beta-cell-function-early/5858/New information on the state of impaired glucose tolerance indicates that the level of beta cell loss is greater than once considered. New treatment regimens are being considered to combat both the insulin sensitivity and beta cell loss for type 2 diabetes. What do health care professionals need toRadiation Nation: The Effects of Cell Phones on Children's Brains
https://reachmd.com/programs/primary-care-today/radiation-nation-effects-cell-phones-childrens-brains/9659/Daniel Debaun explains how radiation from cell phones can be damaging to children's developing brain.From Trials to Real-World Impact: CAR T-Cell Therapy for R/R Large B-Cell Lymphoma
https://reachmd.com/programs/project-oncology/from-trials-to-real-world-impact-car-t-cell-therapy-for-rr-large-b-cell-lymphoma/33230/Based on data from the pivotal ZUMA-7 and TRANSFORM trials, the second-line treatment of relapsed/refractory (R/R) large B-cell lymphoma now includes CAR T-cell therapy, which has been shown to improve progression-free survival and overall survival compared to platinum-based chemoimmunotherapy. RealPersonalizing Care for Large Cell Neuroendocrine Carcinoma
https://reachmd.com/programs/project-oncology/personalizing-care-for-large-cell-neuroendocrine-carcinoma/36458/Treatment for large cell neuroendocrine carcinoma often mirrors small cell protocols, but emerging molecular subtypes are reshaping this approach. Learn how next-generation sequencing, biology, and patient-centered decision-making are advancing individualized therapy with Dr. Junaid Arshad, AssistanClinical Relevancy of Islet Cell Transplantation
https://reachmd.com/programs/focus-on-diabetes/clinical-relevancy-of-islet-cell-transplantation/3843/Can patients with type I diabetes achieve insulin independence with islet cell transplantation? Host Dr. Mary Leuchars explores this question with Dr. R. Paul Robertson, president and scientific director of the Pacific Northwest Diabetes Research Institute and professor of pharmacology and medicineConsidering CAR T-cell Therapy in Follicular Lymphoma
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/considering-car-t-cell-therapy-in-follicular-lymphoma/12932/The treatment landscape for follicular lymphoma is limited, but a recently approved CAR T-cell therapy may change that. Find out how.The Cell Death Pathway: Leveraging Glioblastoma Treatments
https://reachmd.com/programs/neurofrontiers/the-cell-death-pathway-leveraging-glioblastoma-treatments/15111/What role does nutrition have in treating patients with glioblastoma? Tune in for details on a new cell death pathway that could potentially treat tumor cells.Rethinking MacTel: Cell-based Insights for Vision Preservation
https://reachmd.com/programs/cme/Rethinking-MacTel-Cell-Based-Insights-for-Vision-Preservation/35524/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
https://reachmd.com/programs/project-oncology/large-cell-neuroendocrine-carcinoma-care-a-look-at-evolving-approaches/36460/Large cell neuroendocrine carcinoma is a rare, aggressive lung cancer often managed by adapting strategies from small cell and non-small cell lung cancers, starting with platinum-based chemotherapy and guided by molecular testing. As research expands, emerging options like KRAS G12C inhibitors, immuInvestigating CAR T-Cell Therapy for HIV Treatment
https://reachmd.com/programs/clinicians-roundtable/investigating-car-t-cell-therapy-for-hiv-treatment/15159/The second participant in a novel clinical trial to identify a cure for HIV has been dosed. This study is utilizing CAR T-cell therapy to control the virus.